info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Spinal Muscular Atrophy (SMA) Treatment Market By Treatment Type (Gene Therapy, Antisense Oligonucleotides, Small Molecule Drugs, Supportive Therapy); By Disease Type (Type I, Type II, Type III, Type IV); By Route of Administration (Intrathecal, Intravenous, Oral); By End User (Hospitals & Clinics, Homecare Settings, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Spinal Muscular Atrophy (SMA) Treatment Market will witness a robust CAGR of 13.2%, valued at $2.14 billion in 2024, expected to apprecia... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Uveitis Treatment Market By Drug Class (Corticosteroids, Immunosuppressive Agents, Biologics, Cycloplegics, Antimicrobials); By Disease Type (Anterior, Intermediate, Posterior, Panuveitis); By Route of Administration (Topical, Oral, Injectable, Implants); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Uveitis Treatment Market will expand at a robust 6.8% CAGR, valued $812.4 million in 2024 and reaching $1.21 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Rosacea Treatment Market By Treatment Type (Topical Medications, Oral Antibiotics, Laser & Light Therapies, Biologics & Others, Cosmeceuticals & OTC); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Aesthetic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rosacea Treatment Market will witness a robust CAGR of 5.6 %, valued at $ 2.36 billion in 2024, reaching $ 3.27 billion ... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Stroke Management Market By Product Type (Diagnostics, Therapeutic Devices, Medications, Rehabilitation Solutions); By Application (Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attack); By End User (Hospitals & Stroke Centers, ASCs, Rehabilitation Facilities, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stroke Management Market to grow at CAGR 6.4%, from USD 31.5 billion (2024) to USD 48.43 billion (2030)... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Stomach Cancer Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery); By Cancer Type (Adenocarcinoma, Gastrointestinal Stromal Tumor, Lymphoma, Carcinoid Tumors); By End User (Hospitals, Specialty Cancer Clinics, Academic Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stomach Cancer Treatment Market will grow at a CAGR of 7.2%, valued USD 6.8 billion in 2024 and reaching USD 10.4 billion by 2030, driven by preci... Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Prediabetes Market By Product Type (Diagnostic Solutions, Pharmacologic Treatments, Digital Therapeutics & Lifestyle Programs, Nutraceuticals); By Application (Screening & Risk Stratification, Disease Management & Prevention, Patient Engagement & Adherence Support); By End User (Hospitals & Specialty Clinics, Primary Care Settings, Homecare & Self-Testing, Employer & Community Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

INTRODUCTION AND STRATEGIC CONTEXT

The Global Prediabetes Market will surge at 8.6% CAGR—valued at $140.2 billion in 2024 and reaching $229.7 billion by Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Peanut Allergy Treatment Market By Treatment Type (Immunotherapy [Oral, Epicutaneous, Sublingual], Biologic Therapy [Anti-IgE, Anti-IL Agents], Emergency Medication, Adjunct Therapy); By Route of Administration (Oral, Epicutaneous, Injectable, Sublingual); By Age Group (Pediatric, Adolescents, Adults); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Peanut Allergy Treatment Market is driven by oral immunotherapy (OIT) adoption, PALFORZIA, emerging epicutaneous immunotherapy, evolving biologics... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Onychomycosis Treatment Market By Treatment Type (Topical, Oral, Laser, Combination); By Infection Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Total Dystrophic); By Drug Type (Prescription, OTC, Natural Remedies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Onychomycosis Treatment Market will see robust 7.8% CAGR, valued at $ 3.5 billion in 2024 and expected to climb to $ 5.51 billion... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Myasthenia Gravis Treatment Market By Treatment Type (Medication-Based Therapy, Monoclonal Antibodies, Plasma-Based Therapies, Surgical Intervention); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics & Infusion Centers, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Myasthenia Gravis Treatment Market will rise at CAGR 7.1%, from $1.46 billion in 2024 to $2.35 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Cellular Rejuvenation Therapeutics Market By Therapy Type (Gene Therapy & Epigenetic Reprogramming, Senolytic Therapies, Stem Cell-Based Therapies, Exosome and Extracellular Vesicle Therapies); By Application (Neurodegenerative Diseases, Ophthalmology, Dermatology & Aesthetics, Musculoskeletal Disorders, Cardiovascular and Metabolic Disorders); By Delivery Mechanism (Systemic, Localized, Genetic Delivery); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Cellular Rejuvenation Therapeutics Market is poised for a transformative run, advancing at a CAGR of 19.6%, with a valuation of USD 1.34 billion in 2024, expected to re... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Organoid-Based Therapeutic Implants Market By Organoid Type (Liver Organoids, Retinal Organoids, Intestinal Organoids, Pancreatic Organoids); By Application (Ophthalmology, Hepatology, Gastroenterology, Endocrinology, Nephrology); By End User (Academic Medical Centers, Tertiary Hospitals, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Organoid-Based Therapeutic Implants Market is on track to grow at a CAGR of 27.8%, reaching USD 1.36 billion by 2030, up from an estimated USD 312.5 million in ... Read More

Published Date: Oct-2025 | No Of Pages:191 | $ 4485

Psoriasis Treatment Market By Drug Class (Biologics, Topical Therapies, Systemic Non-biologics, Biosimilars); By Route of Administration (Injectable, Oral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Psoriasis Treatment Market recorded a CAGR of 8.1%, valued at USD 32.5 billion in 2024, and is expected to reach USD 51.2 billion Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Androgenetic Alopecia Market By Product Type (Oral Pharmaceuticals, Topical Solutions, Hair Transplant Devices & Procedures, Regenerative Therapies, Cosmetic Camouflaging Products); By Gender (Male, Female); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Androgenetic Alopecia Market is set for CAGR 6.8%, valued at approximately $8.4 billion in 2024, reaching around $12.5 billion by 2030; driven by ... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Invasive Ductal Carcinoma Treatment Market By Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Hormonal Therapy, Targeted Therapy, Immunotherapy); By Therapy Modality (Monotherapy, Combination Therapy, Adjuvant Therapy, Neoadjuvant Therapy); By End User (Hospitals, Cancer Specialty Clinics, ASCs, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Invasive Ductal Carcinoma Treatment Market will experience sustained growth at a CAGR of 7.9%, increasing from $17.6 billion in 2024 to $27.8 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Duchenne Muscular Dystrophy (DMD) Treatment Market By Therapy Type (Corticosteroids, Exon-Skipping Therapies, Gene Therapy, Others); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Duchenne Muscular Dystrophy (DMD) Treatment Market is set to witness significant expansion at a CAGR of 13.8%, reaching $5.1 billion by 2030 from $1.83 billion in ... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Systemic Lupus Erythematosus Treatment Market By Drug Class (Antimalarials, NSAIDs, Corticosteroids, Immunosuppressants, Biologics and Targeted Therapies); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Systemic Lupus Erythematosus Treatment Market is projected to grow at a robust CAGR of 7.9%, valued at $3.65 billion in 2024, and expected to reach $5.75 billion b... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Chemotherapy-Induced Neutropenia (CIN) Treatment Market By Product Type (G-CSFs, Biosimilars, Antibiotics & Antifungals, Others); By Route of Administration (Subcutaneous, Intravenous, Oral); By End User (Hospitals, Oncology Clinics, Homecare Settings, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chemotherapy-Induced Neutropenia (CIN) Treatment Market is forecast to expand at a 6.8% CAGR, valued at 12.3 billion in 2024 and projected to reach Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Epithelioma Treatment Market By Treatment Type (Surgical Intervention, Radiation Therapy, Chemotherapy, Immunotherapy & Targeted Therapy, Photodynamic Therapy); By Cancer Type (Basal Cell Carcinoma, Squamous Cell Carcinoma, Transitional Cell Carcinoma, Other Rare Epitheliomas); By Route of Administration (Oral, Intravenous, Topical, Intralesional); By End User (Hospitals & Specialty Cancer Centers, Ambulatory Surgical Centers, Dermatology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Epithelioma Treatment Market continues to evolve with skin oncology treatments, targeted therapeutics, oncology drug development, radiotherapy adv... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Opioid Use Disorder Treatment Market By Product Type (Medication-Assisted Treatment, Behavioral Therapy & Counseling, Digital Therapeutics); By Route of Administration (Oral, Sublingual, Injectable); By Treatment Setting (Outpatient, Residential/Inpatient, Telehealth); By Distribution Channel (Specialized Opioid Treatment Programs, Hospitals & Clinics, Retail Pharmacies, Online Pharmacies & Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Opioid Use Disorder Treatment Market advances through opioid dependence management, behavioral therapy, medication-assisted treatment, rehabilitat... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Pruritus Therapeutics Market By Drug Class (Antihistamines, Corticosteroids, Calcineurin Inhibitors, Opioid Receptor Modulators, Biologic Therapies); By Route of Administration (Topical, Oral, Injectable); By Disease Type (Atopic Dermatitis, Chronic Kidney Disease–Associated Pruritus, Psoriasis, Cholestatic Pruritus, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pruritus Therapeutics Market is supported by itch treatment, antihistamines, targeted biologics, topical corticosteroids, immune ... Read More

Published Date: OCT-2025 | No Of Pages:169 | $ 4485

Hearing Loss Disease Treatment Market By Treatment Type (Devices, Pharmaceuticals, Surgery, Gene & Cell Therapies); By Hearing Loss Type (Sensorineural, Conductive, Mixed); By End User (Hospitals & ENT Clinics, Ambulatory Surgical Centers, Hearing Aid Retail Chains, Teleaudiology Platforms, Academic & Research Institutes); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hearing Loss Disease Treatment Market recorded a CAGR of 8.4%, valued at $13.4 billion in 2024, and projected to reach $21.74 billion Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Multiple Sclerosis Therapeutics Market By Drug Class (Immunomodulators, Oral Agents, Monoclonal Antibodies, Others); By Route of Administration (Oral, Injectable, Intravenous Infusion); By Disease Type (Relapsing-Remitting MS, Secondary Progressive MS, Primary Progressive MS); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Multiple Sclerosis Therapeutics Market in 2024 was $28.7 billion, and it will reach $42.6 billion by 2030, reflecting a CAGR of 6.8%. Key... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Microsclerotherapy Treatment Market By Treatment Type (Liquid Microsclerotherapy, Foam-Based Microsclerotherapy); By Vein Location (Lower Limb Veins, Facial/Upper Body Veins); By End User (Dermatology Clinics, Aesthetic Clinics & Medspas, Ambulatory Surgical Centers, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Microsclerotherapy Treatment Market will grow at a steady CAGR Of 5.8% , reaching a projected value of USD 111.3 Million By 2030 , up fro... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Ischemic Hepatitis Treatment Market By Treatment Type (Supportive Therapy, Antioxidants & Hepatoprotective Agents, Investigational Therapeutics); By Clinical Setting (Cardiogenic Shock, Septic Shock, Major Surgery & Transplant); By End User (Tertiary Hospitals, Academic Medical Centers, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ischemic Hepatitis Treatment Market is expected to hit USD 3.4 Billion By 2030 from USD 1.9 Billion In 2024 at CAGR Of 9.8%, fueled by N-acetylcys... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Anophthalmia and Microphthalmia Market By Treatment Type (Surgical Interventions, Ocular Prosthetics, Pharmacologic Therapies, Gene & Stem Cell Therapies); By Disease Severity (Bilateral, Unilateral, Syndromic); By End User (Children’s Hospitals, Prosthetic Clinics, Specialty Clinics, Genetic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anophthalmia And Microphthalmia Market is trending upward at CAGR of 7.1%, from USD 352.4 Million in 2024 to USD 534.1 Million by 2030 supported by Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Memory Disorders Market By Disorder Type (Alzheimer’s Disease, Mild Cognitive Impairment, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia); By Diagnostic Method (Neuroimaging, Biomarker Testing, Cognitive Assessment Tools, Genetic Testing); By Treatment Type (Cholinesterase Inhibitors, NMDA Antagonists, Disease-Modifying Therapies, Cognitive/Behavioral Interventions); By End User (Hospitals & Memory Clinics, Primary Care Providers, Long-Term Care Facilities, Home-Based Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Memory Disorders Market is projected to grow at a CAGR of 6.7% , reaching an estimated value of USD 10.9 billion in 2024 and poised to cross USD 16.2 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Obstructive Uropathy Treatment Market By Treatment Type (Ureteral Stents, Percutaneous Nephrostomy, Catheterization, Surgical Intervention, Pharmacological Management); By Cause (Kidney Stones, Benign Prostatic Hyperplasia, Urological Cancers, Congenital Malformations, Neurogenic Bladder, Post-Surgical Complications); By End User (Hospitals, Urology Clinics, Ambulatory Surgical Centers, Dialysis Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Obstructive Uropathy Treatment Market is projected to expand at a 6.5% CAGR, increasing from USD 3.1 billion in 2024 to USD 4.6 billion <... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Herpes Zoster Ophthalmicus Market By Treatment Type (Antivirals, Corticosteroids, Pain Management, Adjunctive Therapies); By Route of Administration (Oral, Topical, Injectable); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Herpes Zoster Ophthalmicus Market will witness a steady CAGR Of 6.1%, valued at USD 1.4 Billion In 2024 , and expected to reach U... Read More

Published Date: OCT-2025 | No Of Pages:161 | $ 4485

Testosterone Replacement Therapy (TRT) Market By Product Type (Injectables, Topical Gels & Creams, Transdermal Patches, Oral Capsules, Nasal Gels, Subcutaneous Implants); By Application (Male Hypogonadism, Gender-Affirming Therapy, Delayed Puberty, Post-Chemotherapy Recovery, Off-Label Use); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By End User (Hospitals, Specialty Clinics, Home Care, Telehealth Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Testosterone Replacement Therapy (TRT) Market is poised to expand at a 6.7% CAGR, valued at USD 2.94 billion in 2024 and projected to reach USD 4.... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Catheter-Directed Thrombolysis Market By Device Type (Infusion Catheters, Guidewires, Thrombolytic Agents, Ultrasound-Assisted Catheters, Accessories); By Indication (Deep Vein Thrombosis, Pulmonary Embolism, Peripheral Arterial Occlusion, Acute Limb Ischemia, Others); By End User (Hospitals, ASCs, Specialty Clinics, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Catheter-Directed Thrombolysis Market will expand at a 6.9% CAGR, rising from $518.4 million in 2024 to $779.3 million by 2030Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Pediatric Cardiology Market By Product Type (Diagnostic Devices, Therapeutic Devices, Surgical Instruments); By Procedure (Non-Invasive Diagnosis, Interventional Cardiology, Surgical Cardiology); By End User (Children’s Hospitals, Multispecialty Hospitals, ASCs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pediatric Cardiology market in 2024 was $3.12 billion, and it will reach $5.09 billion by 2030, registering a CAGR of 7.4%. Key keywords:... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

NTRK Fusion Gene Positive Advanced Solid Tumor Market By Treatment Type (Targeted Therapy, Chemotherapy & Radiotherapy, Immunotherapy); By Diagnostic Technology (NGS Panels, FISH, RT-PCR, IHC); By End User (Academic Institutions, Specialty Clinics, General Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global NTRK Fusion Gene Positive Advanced Solid Tumor Market will witness a robust CAGR of 12.3% , valued at $1.15 billion in 2024 , expected to... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Retinal Detachment Market By Treatment Type (Vitrectomy, Scleral Buckling, Pneumatic Retinopexy, Laser Photocoagulation); By Diagnostic Method (OCT, Fundus Photography, Ultrasound, Slit-Lamp Biomicroscopy); By End User (Hospitals, Ophthalmic Clinics, ASCs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Retinal Detachment Market continues to expand with retinal repair technologies, ophthalmology treatments, vitreoretinal procedures, eye health man... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Lung Cancer Surgery Market By Procedure Type (Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection); By Surgery Approach (Open Thoracotomy, Video-Assisted Thoracoscopic Surgery [VATS], Robotic-Assisted Thoracic Surgery [RATS]); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Cancer Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Lung Cancer Surgery Market will expand at a robust CAGR of 7.3%, rising from $6.2 billion in 2024 to $10.1 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485

Chronic Heart Failure Market By Treatment Type (Pharmaceuticals [ACE Inhibitors, Beta Blockers, SGLT2 Inhibitors, ARBs, MRAs, Ivabradine, Others], Devices [CRT, ICDs, LVADs, Remote Monitoring]); By Disease Type (HFrEF, HFpEF); By End User (Hospitals, Cardiology Clinics, ASCs, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Heart Failure Market is set to grow at 6.8% CAGR, from $15.4 billion in 2024 to $22.9 billion by 2030, driven by... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Head and Neck Cancer Therapeutics Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgical Intervention); By Cancer Type (Oral Cavity Cancer, Oropharyngeal Cancer, Laryngeal Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer, Salivary Gland Tumors); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Head a nd Neck Cancer Therapeutics Market will witness a robust CAGR of 10.7% , valued at $2.85 billion in 2024 , and is expected to appr... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Preterm Birth Prevention and Management Market By Product Type (Pharmaceutical Interventions, Diagnostic and Predictive Tools, Medical Devices and Monitoring Equipment, Neonatal ICU Infrastructure); By Risk Category (High-Risk Pregnancy Interventions, Low-to-Moderate Risk Surveillance); By End User (Hospitals & Maternity Clinics, Research & Academic Institutions, Homecare & Telehealth); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Preterm Birth Prevention And Management Market advances at CAGR 6.9%, valued $2.45 billion (2024) and expected to hit $3.67 billi... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Adult Spinal Deformity Market By Product Type (Surgical Devices, Orthotic Devices, Bone Grafts & Substitutes, Vertebral Augmentation); By Surgery Type (Open, Minimally Invasive); By End User (Hospitals, Specialty Centers, ASCs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Adult Spinal Deformity Market will grow at a 7.6% CAGR, rising from $2.42 billion in 2024 to $3.76 billion by 2030, driv... Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Cryotherapy Market By Product Type (Cryosurgery Devices, Whole-Body Chambers, Localized Equipment, Cryogen Gases); By Application (Oncology, Pain Management, Sports Medicine, Aesthetic Rejuvenation); By End User (Hospitals, Ambulatory Centers, Sports & Wellness Clinics, Home Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cryotherapy Market hits $4.3 billion in 2024 and is on track for $7.1 billion by 2030, delivering 8.23% CAGR as whole-body cryotherapy, <... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Vertebroplasty and Kyphoplasty Market By Product Type (Vertebroplasty Devices, Kyphoplasty Devices); By Application (Osteoporosis, Spinal Tumors, Trauma, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Region (North America, Europe, Asia Pacific, LAMEA); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Vertebroplasty and Kyphoplasty Market will witness a robust CAGR of 10.5% , valued at USD 1.35 ... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Cervical Dysplasia Market By Grade Type (Low-Grade Lesions, High-Grade Lesions, ASC-US); By Diagnostic Method (Pap Smear, HPV DNA Testing, Colposcopy, Biopsy, Liquid-Based Cytology, VIA); By End User (Hospitals, Gynecology Clinics, Diagnostic Labs, ASCs, Community Health Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cervical Dysplasia Market is set for 6.9% CAGR, reaching $2.02 billion by 2030 from $1.34 billion in 2024, boosted by Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Sex Reassignment Surgery Market By Procedure Type (Genital Surgery, Breast/Chest Surgery, Facial Surgery, Body Contouring); By Gender Transition (Male-to-Female, Female-to-Male); By End User (Hospitals, Ambulatory Surgical Centers, Gender Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sex Reassignment Surgery Market trendline shows CAGR 11.6%  $1.45 billion in 2024 to $3.13 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Pediatric Palliative Care Market By Care Type (Hospital-Based, Community-Based, Home-Based, Hospice-Based); By Condition Type (Cancer and Hematologic Disorders, Neuromuscular Diseases, Congenital Disorders, Cardiopulmonary Conditions, Metabolic and Rare Diseases); By Service Model (Inpatient Consultation, Outpatient Clinics, Multidisciplinary Coordination, Pain Management, Psychosocial Counseling); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pediatric Palliative Care Market is projected to grow at CAGR 9.6%, rising from USD 6.8 billion in 2024 to USD 11.9 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Vaginitis Therapeutics Market By Therapeutic Type (Antibiotics, Antifungals, Hormonal Therapy, Probiotics & Microbiome Therapeutics); By Route of Administration (Topical, Oral, Intravaginal); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vaginitis Therapeutics Market will grow at 6.9% CAGR, rising from $3.12 billion in 2024 to $4.67 billion by 2030, driven... Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485

Digital Neurotherapeutics Market By Product Type (Prescription Digital Therapeutics, Non-Prescription Neurotherapeutics); By Therapeutic Application (ADHD, Depression, Anxiety, Chronic Pain, Alzheimer's, Insomnia, Substance Use Disorders); By End User (Hospitals, Neurology Centers, Homecare Settings, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Digital Neurotherapeutics Market is valued at $2.4 billion in 2024 and is projected to grow at a 23.5% CAGR to nearly $8.6 billion Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Bone Spur Market By Product Type (Pharmacological Treatment, Surgical Tools & Devices, Orthopedic Implants & Accessories, Therapeutic Aids); By Application (Spinal Bone Spurs, Heel Spurs, Hip and Knee Osteophytes, Shoulder and Elbow Osteophytes, Others); By End User (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bone Spur Market will witness a moderate but steady CAGR of 5.8% , valued at approximately USD 1.92 billion in 2024 , and is expected to appreciate and reach USD 2... Read More

Published Date: OCT-2025 | No Of Pages:161 | $ 4485

Surgical Sphincteroplasty Market By Procedure Type (Primary Sphincteroplasty, Overlapping Sphincteroplasty, Muscle Transposition); By Surgical Approach (Open Surgery, Minimally Invasive Surgery); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Surgical Sphincteroplasty Market is forecast to grow at a 7.2% CAGR, valued at $1.12 billion in 2024 and projected to reach $1.81 billion... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Tinnitus Management Market By Product Type (Hearing Aids, Sound Masking Devices, Neuromodulation Devices, Tinnitus Apps); By Therapy Approach (Sound Therapy, Cognitive Behavioral Therapy, Pharmacological, Neuromodulation); By End User (Hospitals & ENT Clinics, Audiology Centers, Home Care, Military & Veterans); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tinnitus Management Market will witness a robust CAGR of 7.4% , valued at $2.57 billion in 2024 , expected to appreciate and reach $4.17 billion b... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Rotator Cuff Injury Treatment Market By Treatment Type (Surgical Treatments, Non-Surgical Treatments); By Injury Type (Partial-Thickness Tear, Full-Thickness Tear, Tendinopathy); By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rotator Cuff Injury Treatment Market is set to grow at a 6.8% CAGR, increasing from $7.4 billion in 2024 to $11.0 billion by 2030... Read More

Published Date: OCT-2025 | No Of Pages:186 | $ 4485

Varicose Vein Treatment Market By Treatment Type (Endovenous Ablation, Sclerotherapy, Vein Stripping, Ligation, Compression Therapy, Adhesive Closure); By End User (Hospitals, ASCs, Vein Clinics, Homecare); By Mode of Treatment (Minimally Invasive, Non-Invasive, Surgical); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Varicose Vein Treatment Market will climb from $1.11 billion in 2024 to $1.66 billion by 2030 with a 7.5% CAGR, driven by innovative endother... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Sclerotherapy Market By Type of Agent (Detergent-Based Sclerosants, Osmotic Agents, Chemical Irritants); By Treatment Type (Liquid, Foam, Ultrasound-Guided); By Application (Varicose Veins, Spider Veins, Hemorrhoids, Vascular Malformations); By End User (Hospitals, ASCs, Specialty Clinics, Dermatology Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sclerotherapy Market will grow at 8.36% CAGR, valued $1.68 billion in 2024 and reaching $2.08 billion by 2030 amid Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Colorectal Surgery Market By Product Type (Stapling Devices, Sutures, Robotic Systems, Energy Devices, Others); By Surgery Type (Colorectal Cancer Surgery, Hemorrhoidectomy, Colectomy, Fistula Repair, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Colorectal Surgery Market will climb at CAGR 6.9%, valued $15.4 billion in 2024 and reaching $23.1 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Claudin 18.2 Targeted Therapy Market By Product Type (Monoclonal Antibodies, Antibody-Drug Conjugates, CAR-T Cell Therapies); By Indication (Gastric and Gastroesophageal Junction Cancer, Pancreatic Cancer, Lung Adenocarcinoma, Others); By Therapeutic Modality (Antibody-Based Therapy, Bispecific Antibody Constructs, Cell Therapy, Small Molecule Inhibitors); By End User (Hospitals & Oncology Centers, Specialty Clinics, Academic & Research Institutions, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

1. Introduction and Strategic Context

The Global Claudin 18.2 Targeted Therapy Market will experience substantial momentum between 2024 and 2030, with an estimated value of around USD 1.8 billion in 2024, projected to reach US... Read More

Published Date: MAR-2025 | No Of Pages:181 | $ 4485

Menopause Market By Product Type (Hormone Replacement Therapy [HRT], Non-Hormonal Treatments, Herbal Supplements); By Treatment Option (Pharmacological, Non-Pharmacological); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Menopause Market is expected to be valued at $20.5 billion in 2024 , with projections to reach $34.5 billion by 2030 , growing at a CAGR of 8.5%Read More

Published Date: OCT-2025 | No Of Pages:157 | $ 4485

Mesotherapy Market By Product Type (Mesotherapy Solutions, Devices, Kits & Consumables); By Application (Aesthetic Enhancement, Hair Restoration, Pain Management, Scar & Stretch Mark Treatment, Fat and Cellulite Reduction); By End User (Aesthetic Clinics, Hospitals & Dermatology Centers, Home Use, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mesotherapy Market is set to expand at an 11.2% CAGR, growing from $768.4 million in 2024 to $1.44 billion by 2030, fueled by min... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Kyphosis Treatment Market By Treatment Type (Surgical Intervention, Non-Surgical Management); By Disease Type (Postural, Congenital, Scheuermann’s, Nutritional/Pathological); By End User (Hospitals, Specialty Clinics, ASCs, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Kyphosis Treatment Market will witness a robust CAGR of 6.8% , valued at $2.35 billion in 2024 , and is expected to appreciate and reach $3.5 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Diabetic Foot Ulcer Treatment Market By Product Type (Wound Care Dressings, Antibiotics, Biological Therapies, Others); By Treatment Modality (Topical Treatments, Surgical Interventions, Biological Therapies); By End-User (Hospitals, Clinics, Home Care, Long-term Care Facilities, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Diabetic Foot Ulcer Treatment Market forecast signals substantial growth at a CAGR of 5.6%, climbing from $2.6 billion in 2024 to Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Aortic Coarctation Market By Treatment Type (Surgical Repair, Balloon Angioplasty, Stent Implantation); By Age Group (Neonates and Infants, Children and Adolescents, Adults); By End User (Hospitals, Specialty Cardiac Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aortic Coarctation Market is set to grow at a 7.4% CAGR, valued at USD 561.8 million in 2024 and projected to reach USD 921.3 million Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Blepharoplasty Market By Procedure Type (Upper Eyelid Surgery, Lower Eyelid Surgery, Combination, Revision, Transconjunctival, Laser-Assisted); By Gender (Male, Female, Non-Binary); By End User (Hospitals, ASCs, Cosmetic Clinics, Medical Spas); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blepharoplasty Market set to expand from USD 4.3 billion in 2024 to USD 6.9 billion by 2030 at a 7.2% CAGR, driven by rising cosmetic procedures, medical tourism, ... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Achondrogenesis Market By Type (Achondrogenesis Type 1A, Type 1B, Type 2); By Diagnostic Modality (Genetic Testing, Ultrasound & Imaging, Amniocentesis, Carrier Screening); By End User (Hospitals, Diagnostic Labs, Genetic Counseling Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Achondrogenesis Market is expected to witness steady growth at 6.8% CAGR, increasing from $164.3 million in 2024 to $244.6 million by 2030, driven by Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

Facial Palsy Market By Treatment Type (Surgical Procedures, Non-Surgical Therapies, Advanced Therapies); By Cause of Condition (Bell’s Palsy, Traumatic Injury, Congenital, Tumor-Induced, Infectious & Autoimmune); By End User (Hospitals, Specialty Clinics, Rehabilitation Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Facial Palsy Market is expected to witness sustained growth at a CAGR of 6.9%, rising from $3.1 billion in 2024 to $4.6 billion by 2030, backed by Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

Dysphagia Management Market By Product Type (Thickening Agents and Nutritional Supplements, Feeding Tubes and Enteral Devices, Diagnostic and Monitoring Tools, Swallowing Therapy and Assistive Technologies); By Indication (Neurological Disorders, Head and Neck Cancer, GERD, Others); By End User (Hospitals and Specialty Clinics, Home Healthcare Settings, Rehabilitation Centers, Long-Term Care Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dysphagia Management Market is expected to register a robust 6.8% CAGR, valued at $4.75 billion in 2024 and forecast to reach $7.05 billionRead More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Osteosarcoma Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Surgery, Radiotherapy); By Route of Administration (Intravenous, Oral, Intra-arterial); By Patient Demographic (Pediatric, Young Adults, Adults); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Osteosarcoma Market will register a healthy 6.8% CAGR, expanding from $1.54 billion in 2024 to $2.30 billion by 2030, propelled by personalized me... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Paraneoplastic Syndrome Market By Syndrome Type (Neurologic, Endocrine, Dermatologic, Hematologic, Others); By Diagnostic Modality (Serological Testing, Imaging Techniques, CSF Analysis, Electrophysiological Tests, Others); By Treatment Type (Immunosuppressive Therapy, Plasmapheresis and IVIG, Anti-Tumor Therapy, Monoclonal Antibody Therapy, Supportive Care); By End User (Hospitals & Clinics, Diagnostic Labs, Academic Institutes, Pharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Paraneoplastic Syndrome Market will witness a steady CAGR of 7.4% , valued at USD 412.7 million in 2024 , and is expected to appreciate and reach USD 675.9 million... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Brain Ischemia Market By Product Type (Diagnostics, Pharmaceuticals, Interventional Devices, Monitoring Equipment); By Type of Ischemia (Focal, Global, Silent, Chronic Hypoperfusion); By End User (Hospitals, Diagnostic Imaging Centers, ASCs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Brain Ischemia Market is anticipated to advance at a robust 6.9% CAGR, valued at $5.2 billion in 2024 and expected to reach $7.8 billion by 2030, led by <... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Heart Transplantation Therapeutics Market By Drug Class (Immunosuppressive Agents, Induction Therapies, Anti-infective Therapies, Others); By Therapy Stage (Pre-transplant Stabilization, Intra-operative Management, Post-transplant Maintenance); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Transplant Hospitals, Academic Medical Centers, Specialty Clinics, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Heart Transplantation Therapeutics Market will witness a robust CAGR of 9.1% , valued at $1.38 billion in 2024 , and is expected to appreciate and reach $2.58 bill... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485

Myocardial Ischemia Market By Product Type (Pharmaceuticals, Medical Devices, Digital Health Solutions); By Diagnostic Modality (ECG, Stress Testing, MPI, CCTA, MRI); By Treatment Setting (Hospitals, ASCs, Diagnostic Centers, Telehealth); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Myocardial Ischemia Market is expected to advance at a robust 7.93% CAGR, from $4.3 billion in 2024 to $7.23 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:198 | $ 4485

Astigmatism Market By Product Type (Eyeglasses, Contact Lenses [Toric, RGP, Ortho-K], Surgical Systems [LASIK, PRK, SMILE], Intraocular Lenses); By Treatment Type (Non-Surgical Correction, Surgical Correction); By End User (Hospitals, ASCs, Optical Stores, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Astigmatism Market is set to expand at a robust CAGR of 8.9%, valued at USD 3.9 billion in 2024 and projected to reach USD 6.5 billion by 2030, driven by ... Read More

Published Date: OCT-2025 | No Of Pages:181 | $ 4485

Myocardial Infarction Market By Treatment Type (Thrombolytic Therapy, Antiplatelet Agents, Beta Blockers, ACE Inhibitors, Statins, Coronary Angioplasty & Stenting, CABG); By Diagnosis (ECG, Biomarkers, Echocardiography, Angiography, Cardiac MRI); By End User (Hospitals & Cardiac Care Centers, ASCs, Labs, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Myocardial Infarction Market will witness a robust CAGR of 7.21%, valued at $17.8 billion in 2024 and expected to reach $26.5 billion by 2030, driven by <... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Tachycardia Market By Treatment Type (Pharmacological Therapy, Device-Based Therapy, Ablation Procedures, Electrical Cardioversion); By Tachycardia Type (SVT, AF, VT, Sinus Tachycardia, Others); By End User (Hospitals, Cardiology Clinics, ASCs, Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tachycardia Market will witness a robust CAGR of 7.8% , valued at $9.6 billion in 2024 , expected to appreciate and reach $15.1 billion by 2030 , con... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Amblyopia Market By Treatment Type (Eyeglasses, Eye Patches, Atropine Drops, Vision Therapy, Digital Therapeutics); By Age Group (0–6 Years, 7–12 Years, 13–17 Years, Adults); By End User (Hospitals, Ophthalmology Clinics, Homecare Settings, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Amblyopia Market will witness a robust CAGR of 7.8% , valued at $4.6 billion in 2024 , expected to appreciate and reach $7.2 billion by 2030 , confir... Read More

Published Date: OCT-2025 | No Of Pages:169 | $ 4485

Uveal Melanoma Market By Treatment Type (Radiation Therapy, Immunotherapy, Liver-Directed Therapy, Targeted Therapy, Surgical Intervention); By Disease Stage (Localized, Metastatic); By Route of Administration (Oral, Intravenous, Intraocular, Hepatic Arterial); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Uveal Melanoma Market is projected to experience a moderate but significant growth trajectory, expanding at a CAGR of 6.8 % during the forecast period. It... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Mitochondrial-Based Therapeutics Market By Therapy Type (Small Molecule Drugs, Gene Therapies, Peptide-Based Therapeutics, Mitochondrial Replacement Therapies); By Application (Neurology, Metabolic Disorders, Cardiology, Oncology, Inherited Mitochondrial Diseases); By End User (Biopharmaceutical Companies, Academic & Research Institutes, Specialty Hospitals & Clinics, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Mitochondrial-Based Therapeutics Market will witness a robust CAGR of 10.8%, valued at USD 1.7 billion in 2024, expected to reach around USD 3.5 billion by 2030... Read More

Published Date: MAY-2025 | No Of Pages:156 | $ 4485

MENIN Inhibitors Market By Drug Type (Single-Agent MENIN Inhibitors, Combination MENIN Inhibitors); By Indication (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Other Indications); By Route of Administration (Oral, Intravenous); By End User (Hospitals & Oncology Centers, Specialty Clinics, Research Institutes, Pharmacies & Distributors); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

1. Introduction and Strategic Context

The Global MENIN Inhibitors Market will witness steady expansion at a CAGR of 8.9%, rising from USD 520.2 million in 2024 to USD 872.1 million by 2030, fueled by ... Read More

Published Date: MAY-2025 | No Of Pages:185 | $ 4485

Interstitial Cystitis Market By Product Type (Oral Medications, Intravesical Therapies, Medical Devices & Diagnostics); By Route of Administration (Oral, Intravesical, Parenteral & Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Interstitial Cystitis Market will grow at an estimated 6.8% CAGR, valued at $1.43 billion in 2024 and projected to reach $2.13 billion by 2030, driven ... Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Critical Care Therapeutics Market By Product Type (Anti-infectives, Vasopressors, Sedatives, Neuromuscular Blockers, Corticosteroids, Biologics); By Therapeutic Area (Sepsis, Respiratory Failure, Trauma, Cardiac Arrest, Post-operative Complications); By Route of Administration (Intravenous, Intramuscular, Intranasal); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Critical Care Therapeutics Market will witness steady growth at a 7% CAGR, increasing from USD 56.3 billion in 2024 to nearly USD 84.5 billion by 2030,... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Premature Ejaculation Treatment Market By Treatment Type (Topical Agents, Oral Therapies, Behavioral Therapy, Others); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Premature Ejaculation ( PE ) Treatment Market will witness a modest CAGR of 5.6%, valued at USD 1.47 billion in 2024, and is expected to reach USD 2.04 billion by 2030,... Read More

Published Date: SEP-2025 | No Of Pages:188 | $ 4485

Mycosis Fungoides Treatment Market By Treatment Type (Biologic Therapy, Phototherapy, Chemotherapy, Topical Treatments); By Therapy Method (Systemic Therapy, Localized Therapy); By End User (Hospitals, Specialty Clinics, Research Institutes, Diagnostic Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Mycosis Fungoides Treatment Market is poised for steady growth, with a projected compound annual growth rate (CAGR) of approximately 6.3% from 2024 to ... Read More

Published Date: SEP-2025 | No Of Pages:178 | $ 4485

Lateral Epicondylitis Treatment Market By Treatment Type (Pharmacological Therapy, Physical Therapy and Bracing, Minimally Invasive Procedures, Surgical Intervention); By End User (Hospitals, Orthopedic Clinics, Rehabilitation Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Lateral Epicondylitis Treatment Market is projected to expand from USD 1.2 billion in 2024 to USD 1.7 billion by 2030, growing at a CAGR of 5.9 percent... Read More

Published Date: SEP-2025 | No Of Pages:195 | $ 4485

PKMYT1 Inhibitors Market By Indication (Ovarian Cancer, Endometrial Cancer, Breast & Prostate, Other Solid Tumors); By Line of Therapy (Relapsed/Refractory, First-Line & Second-Line); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2035

1. Introduction and Strategic Context

The Global PKMYT1 Inhibitors Market is poised for rapid growth, projected to rise from USD 90.2 million in 2024 to USD 460 million by 2030, accelerating post... Read More

Published Date: SEP-2025 | No Of Pages:150 | $ 4485

CTLA4 Inhibitors Market By Drug Type (Monotherapies, Combination Therapies); By Indication (Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Others); By End User (Hospitals, Specialty Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global CTLA4 Inhibitors Market is poised for significant growth, with an estimated market size of USD 4.5 billion in 2024, projected to expand at a CAGR of 10.8%Read More

Published Date: SEP-2025 | No Of Pages:190 | $ 4485

Vitiligo Treatment Market By Treatment Type (Topical Therapy, Oral Therapy, Light Therapy, Surgical Procedures); By Route of Administration (Topical, Oral, Injectable); By End User (Dermatology Clinics, Hospitals, Tele-dermatology, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Vitiligo Treatment Market is expected to reach approximately USD 2.1 billion by 2030 , growing from an estimated USD 1.2 billion in 2024 , at a project... Read More

Published Date: SEP-2025 | No Of Pages:166 | $ 4485

Throat Cancer Therapeutics Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgical Intervention); By Cancer Subtype (Laryngeal Cancer, Pharyngeal Cancer, Tonsil Cancer); By Route of Administration (Oral, Intravenous, Topical/Localized); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Throat Cancer Therapeutics Market is estimated to be valued at 6.1 billion dollars in 2024 , and is pr ojected to grow to 9.7 billion dollars by 2030 ,... Read More

Published Date: SEP-2025 | No Of Pages:160 | $ 4485

Pulmonary Edema Therapeutics Market By Drug Class (Diuretics, Vasodilators, ACE Inhibitors & ARBs, Others); By Indication (Cardiogenic Pulmonary Edema, Non-Cardiogenic Pulmonary Edema, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care); By Region, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Pulmonary Edema Therapeutics Market is poised to grow steadily, with a CAGR of 6.8% from 2024 to 2030, and is projected to reach a market siz... Read More

Published Date: SEP-2025 | No Of Pages:169 | $ 4485

Phosphoinositide 3-Kinase Inhibitors Market By Drug Type (Idelalisib, Copanlisib, Alpelisib, Duvelisib, Others); By Application (Hematologic Cancers, Breast Cancer, Solid Tumors, Others); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market is projected to grow at a 9.7% CAGR, expanding from USD 1.56 billion in 2024 to USD 2.73 billion by 2030Read More

Published Date: SEP-2025 | No Of Pages:197 | $ 4485

Malabsorption Syndrome Market By Type (Celiac Disease, Lactose Intolerance, Chronic Pancreatitis, Others); By Diagnostic Method (Endoscopy, Blood Tests, Stool Tests, Imaging); By Treatment Option (Enzyme Replacement Therapy, Gluten-Free Diet, Pharmacological Treatments); By Region, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Malabsorption Syndrome Market is expected to experience steady growth in the coming years, driven by increasing global awareness of gastrointestinal diseases, an aging population, and advances in diagnostic te... Read More

Published Date: SEP-2025 | No Of Pages:168 | $ 4485

Gastrointestinal Stromal Tumor Treatment Market By Drug Type (Tyrosine Kinase Inhibitors, Immunotherapy, Chemotherapy); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Oncology Clinics, Academic Medical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Gastrointestinal Stromal Tumor ( GIST ) Treatment Market is poised to expand at a CAGR of 7.9% , reaching USD... Read More

Published Date: SEP-2025 | No Of Pages:173 | $ 4485

Neuromyelitis Optica Spectrum Disorder Market By Therapy Type (Monoclonal Antibodies, Corticosteroids & Immunosuppressants, Plasma Exchange Therapy); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Neuromyelitis Optica Spectrum Disorder Market is poised to expand at a CAGR of 8.7% , with a value of USDRead More

Published Date: SEP-2025 | No Of Pages:193 | $ 4485

KAT6 Inhibitors Market By Program Type (PF-07248144, Dual KAT6/GCN5, Selective KAT6 Inhibitors, KAT6 Degraders); By Indication (HR+/HER2– Breast Cancer, Prostate Cancer, Hematologic Malignancies); By Line of Therapy (Third-Line, Second-Line, First-Line Combination); By Geography, Segment Revenue Estimation, Forecast, 2024–2035

1. Introduction and Strategic Context

The Global KAT6 Inhibitors Market is set to grow at a 42–46% CAGR, expanding from USD 70–90 million in 2024 to USD 2.5–3.0 billion by 2030, driv... Read More

Published Date: SEP-2025 | No Of Pages:156 | $ 4485

Acne Treatment Market By Product Type (Topical Treatments, Oral Medications, OTC Formulations, Combination Therapies); By Treatment Modality (Pharmaceutical, Light-Based, Herbal, Cosmeceutical); By End User (Dermatology Clinics, Retail Consumers, Teledermatology Platforms, Aesthetic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Acne Treatment Market is projected to grow steadily at a CAGR of 5.8% , estimated at USD 11.6 billion in 2024 and likely to reach around USD 16.3 billion by 203... Read More

Published Date: SEP-2025 | No Of Pages:187 | $ 4485

Ursodeoxycholic Acid Market By Product Type (Synthetic UDCA, Natural UDCA); By Route of Administration (Oral Tablets and Capsules, Suspension and Liquid Formulations); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Ursodeoxycholic Acid Market is projected to expand at a steady CAGR of 5.9% , rising from an estimated USD 823 million in 2024 to about USD 1.16 billion by 2030... Read More

Published Date: SEP-2025 | No Of Pages:168 | $ 4485

Tardive Dyskinesia Therapeutics Market By Drug Type (VMAT2 Inhibitors, Antipsychotics); By Route of Administration (Oral, Injectable); By End User (Hospitals, Specialty Clinics, Research Institutions, Diagnostic Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Tardive Dyskinesia (TD) Therapeutics Market is projected to grow at a 10.1% CAGR, expanding from USD 2.5 billion in 2024 to USD 4.45 billion by 2030, d... Read More

Published Date: SEP-2025 | No Of Pages:164 | $ 4485

TEAD Inhibitors Market By Mechanism of Action (Lipid-pocket Inhibitors, PPI Disruptors, Covalent Inhibitors, Isoform-Selective Inhibitors); By Tumor Type (NF2-Altered Tumors, Mesothelioma, YAP/TAZ Fusion–Driven Tumors, Hippo-Pathway Solid Tumors); By Region (North America, Europe, Asia-Pacific, Rest of World); Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global TEAD Inhibitors Market expected to reach USD 0.5–1.0 billion by 2030 and expand to USD 2–3+ billion by 2035, driven by Hippo pathway oncology, NF2-a... Read More

Published Date: SEP-2025 | No Of Pages:159 | $ 4485

Large Molecule Injectable Drugs Market By Molecule Type (Monoclonal Antibodies, Peptides & Proteins, Cell and Gene Therapies, Fusion Proteins & Enzymes); By Therapeutic Area (Oncology, Autoimmune Diseases, Metabolic Disorders, Rare Diseases, Neurology & Hematology); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail & Outpatient Clinics, Online/DTC); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Large Molecule Injectable Drugs Market is on track to grow at a CAGR of 9.1% , reaching USD 256.1 billion by 2030 , up from an estimated USD 152.6 billion in 20... Read More

Published Date: SEP-2025 | No Of Pages:199 | $ 4485

Treatment-Resistant Depression Therapeutics Market By Drug Class (NMDA Receptor Antagonists, Atypical Antipsychotics, Monoamine-Based Antidepressants, Psychedelic-Based Molecules, Others); By Route of Administration (Oral, Intranasal, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Treatment-Resistant Depression (TRD) Therapeutics Market is projected to grow at a 9.1% CAGR, expanding from USD 4.2 Billion in 2024 to USD 7.1 Billion by 2030,... Read More

Published Date: SEP-2025 | No Of Pages:196 | $ 4485

Systemic Mastocytosis Treatment Market By Drug Class (Tyrosine Kinase Inhibitors, Antihistamines, Immunomodulators, Corticosteroids); By Disease Subtype (Indolent SM, Aggressive SM, Smoldering SM, Mast Cell Leukemia); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Systemic Mastocytosis Treatment Market is projected to reach USD 1.9 Billion by 2030, up from USD 1.2 Billion in 2024, expanding at a 7.8% CAGR, suppor... Read More

Published Date: SEP-2025 | No Of Pages:160 | $ 4485

Nontuberculous Mycobacteria (NTM) Market By Product Type (NTM Therapeutics, NTM Diagnostics); By Infection Type (Pulmonary, Disseminated, Skin/Soft Tissue); By Route of Administration (Oral, Inhalation, Parenteral); By End User (Hospitals & Specialty Clinics, Diagnostic Laboratories, Outpatient Clinics, Pharmacies & Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Nontuberculous Mycobacteria Market is projected to grow at a robust CAGR of 8.9% , rising from USD 1.73 billion in 2024 to nearly USD 2.92 bill... Read More

Published Date: SEP-2025 | No Of Pages:172 | $ 4485

Infantile Spasms Therapeutics Market By Drug Class (Hormonal Therapies, Antiepileptic Drugs, Adjunct Therapies); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Infantile Spasms Therapeutics Market to grow at a 6.7% CAGR, expanding from USD 257.5 million in 2024 to USD 381.2 million by 2030, driven by rare pediatric epi... Read More

Published Date: AUG-2025 | No Of Pages:178 | $ 4485

Hyperparathyroidism Treatment Market By Disease Type (Primary, Secondary, Tertiary Hyperparathyroidism); By Treatment (Surgical, Drug Therapy, Others); By End User (Hospitals & Specialty Centers, Ambulatory Surgical Centers, Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Hyperparathyroidism Treatment Market is projected to grow at a 5.8% CAGR, expanding from USD 2.1 billion in 2024 to USD 3.0 billion by 2030, driven by ... Read More

Published Date: AUG-2025 | No Of Pages:179 | $ 4485

Splenomegaly Therapeutics Market By Drug Type (Chemotherapy, Immunotherapy, Enzyme Replacement Therapy, Corticosteroids); By Treatment Modality (Oral Therapies, Intravenous Therapies); By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Splenomegaly Therapeutics Market will experience steady growth during the forecast period of 2024–2030, with a projected market value of USD 2.7 billion in 2024 and an expected reach of ... Read More

Published Date: AUG-2025 | No Of Pages:197 | $ 4485